Alivus Life Sciences Ltd.

With no major difference for the quarter endedDecember 2021 , the total revenue stood at Rs. 5224.99  millions.The Company has registered profit of Rs. 1037.13  millions for the quarter ended December 2021, a growth of 11.09%  over Rs. 933.61 millions millions achieved in the corresponding quarter of last year.The company reported a degrowth in operating Profit to 1495.98 millions from 1552.00 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202112	202012	% Var	202112	202012	% Var	202112	202012	% Var
Sales	5224.99	5002.29	4.45	5224.99	5002.29	4.45	5224.99	5002.29	4.45
Other Income	35.34	3.72	850.00	35.34	3.72	850.00	35.34	3.72	850.00
PBIDT	1495.98	1552.00	-3.61	1495.98	1552.00	-3.61	1495.98	1552.00	-3.61
Interest	0.61	216.50	-99.72	0.61	216.50	-99.72	0.61	216.50	-99.72
PBDT	1495.37	1335.50	11.97	1495.37	1335.50	11.97	1495.37	1335.50	11.97
Depreciation	97.39	83.60	16.50	97.39	83.60	16.50	97.39	83.60	16.50
PBT	1397.98	1251.90	11.67	1397.98	1251.90	11.67	1397.98	1251.90	11.67
TAX	360.85	318.29	13.37	360.85	318.29	13.37	360.85	318.29	13.37
Deferred Tax	41.49	20.78	99.66	41.49	20.78	99.66	41.49	20.78	99.66
PAT	1037.13	933.61	11.09	1037.13	933.61	11.09	1037.13	933.61	11.09
Equity	245.05	19.60	1150.26	245.05	19.60	1150.26	245.05	19.60	1150.26
PBIDTM(%)	28.63	31.03	-7.72	28.63	31.03	-7.72	28.63	31.03	-7.72